Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Establishing MIC breakpoints and the interpretation of <i>in vitro</i> susceptibility tests

1 Jul 2001

Abstract excerpt

The purpose of undertaking susceptibility testing, by whatever method, is to attempt to integrate the susceptibility of a population of potential pathogens with the pharmacokinetics of the antimicrobial and, whenever possible, to review this relationship in the light of clinical experience following therapy in clinical trials. Breakpoints are discriminatory antimicrobial concentrations used in the interpretation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotics Pharmacokinetics and Efficacy
Share to Bacterial Identification and Susceptibility Testing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11420334
DOI: 10.1093/jac/48.suppl_1.17

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Establishing MIC breakpoints and the interpretation of <i>in vitro</i> susceptibility testsPMID 11420334Read ↗

European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteriaSemantic proximity Read ↗

Susceptibility testing methods, resistance and breakpoints: what do these terms really mean?Semantic proximity Read ↗

Setting and Revising Antibacterial Susceptibility BreakpointsSemantic proximity Read ↗

Critical Assessment of Issues Applicable to Development of Antimicrobial Susceptibility Testing BreakpointsSemantic proximity Read ↗

Setting Antimicrobial Susceptibility Testing Breakpoints: A Primer for Pediatric Infectious Diseases Specialists on the Clinical and Laboratory Standards Institute ApproachSemantic proximity Read ↗

The 2014 Garrod Lecture: EUCAST – are we heading towards international agreement?Semantic proximity Read ↗

A Long Journey from Minimum Inhibitory Concentration Testing to Clinically Predictive Breakpoints: Deterministic and Probabilistic Approaches in Deriving BreakpointsSemantic proximity Read ↗

Don't Get Wound Up: Revised Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosaSemantic proximity Read ↗

The Clinical Predictive Value (or Lack Thereof) of the Results of <i>In Vitro</i> Antimicrobial Susceptibility TestsSemantic proximity Read ↗

Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCASTSemantic proximity Read ↗

The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approachSemantic proximity Read ↗

Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.